This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Paul E Gormisky: Innovator in Heterocyclic PAD4 Inhibitors
Introduction
Paul E Gormisky is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit the PAD4 enzyme. His work is crucial for advancing treatments for diseases associated with PAD4 enzyme activity.
Latest Patents
Gormisky holds a patent for "Heterocyclic PAD4 inhibitors." This patent describes substituted heterocyclic compounds of Formula (Ia), which serve as inhibitors of PAD4. The disclosure includes methods for preparing these compounds, pharmaceutical compositions that comprise them, and their use in treating diseases linked to PAD4 enzyme activity. He has 1 patent to his name.
Career Highlights
Throughout his career, Gormisky has been associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work there has focused on innovative solutions in drug development, particularly in the area of enzyme inhibitors.
Collaborations
Gormisky has collaborated with esteemed colleagues such as Kumaravel Selvakumar and Venkatram Reddy Paidi. These partnerships have enhanced the research and development efforts in their respective fields.
Conclusion
Paul E Gormisky's contributions to the field of pharmaceutical chemistry, particularly through his patent on PAD4 inhibitors, highlight his role as an innovator. His work continues to impact the development of treatments for diseases associated with PAD4 enzyme activity.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile